
Atea Pharmaceuticals, Inc.
AVIRHealthcare|Biotechnology|US
$4.31
+0.09 (+2.13%)
DCF Value
$1.01
Tangible Book / Share
$2.55
Cash / Share
$2.74
Ownership Breakdown
75.5%
Float
80.2M
Shares Outstanding
60.5M
Float Shares
Major Holders (24)
Combined: 111.3%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Abigail P. Johnson | Individual | 15.00% | 11,950,771 | May 6, 2026 | 13D/G |
| FMR LLC | Holding company | 15.00% | 11,950,771 | May 6, 2026 | 13D/G |
| Jean-Pierre Sommadossi | Individual | 10.10% | 8,876,453 | May 14, 2025 | 13D/G |
| Leonard Braden Michael | Individual | 9.90% | 7,810,000 | Feb 9, 2026 | 13D/G |
| BML Investment Partners, L.P. | Partnership | 9.60% | 7,490,000 | Feb 9, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 7.10% | 6,082,350 | Apr 23, 2025 | 13D/G |
| JPM Partners LLC | Other | 6.90% | 5,866,025 | May 14, 2025 | 13D/G |
| Tang Capital Management, LLC | Other | 6.00% | 4,814,700 | Oct 6, 2026 | 13D/G |
| Kevin Tang | Individual | 6.00% | 4,814,700 | Oct 6, 2026 | 13D/G |
| Radoff Bradley Louis | Individual | 4.00% | 3,380,100 | Apr 17, 2025 | 13D/G |
| EcoR1 Capital, LLC | IA, OO | 4.00% | 3,341,653 | Feb 14, 2025 | 13D/G |
| Oleg Nodelman | HC, IN | 4.00% | 3,341,653 | Feb 14, 2025 | 13D/G |
| EcoR1 Capital Fund Qualified, L.P. | Partnership | 3.70% | 3,156,745 | Feb 14, 2025 | 13D/G |
| Tang Capital Partners, LP | Partnership | 3.10% | 2,488,519 | Oct 6, 2026 | 13D/G |
| Tang Capital Partners International, LP | Partnership | 2.10% | 1,665,077 | Oct 6, 2026 | 13D/G |
| Torok Michael | Individual | 1.80% | 1,500,000 | Apr 17, 2025 | 13D/G |
| JEC II Associates, LLC | Other | 1.50% | 1,300,000 | Apr 17, 2025 | 13D/G |
| Tang Capital Partners III, Inc | Corporation | 0.80% | 661,104 | Oct 6, 2026 | 13D/G |
| Radoff Family Foundation | Corporation | 0.20% | 185,000 | Apr 17, 2025 | 13D/G |
| Flynn James P. | Individual | 0.10% | 54,000 | Apr 17, 2025 | 13D/G |
| Nerium Capital LLC | Other | 0.10% | 54,000 | Apr 17, 2025 | 13D/G |
| Nerium Partners LP | Partnership | 0.10% | 54,000 | Apr 17, 2025 | 13D/G |
| Mos PTC, LLC | Other | 0.10% | 100,000 | Apr 17, 2025 | 13D/G |
| The MOS Trust | Other | 0.10% | 100,000 | Apr 17, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 5,314,686 acquired · 1,535,395 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lucidi Bruno | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| Lucidi Bruno | director | Jun 18, 2026 | AWARD | 37,700 | $4.36 | $164.4K | Form 4 |
| Lucidi Bruno | director | Jun 18, 2026 | AWARD | 26,700 | — | — | Form 4 |
| Lucidi Bruno | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| BERGER FRANKLIN M | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| BERGER FRANKLIN M | director | Jun 18, 2026 | AWARD | 37,700 | $4.36 | $164.4K | Form 4 |
| BERGER FRANKLIN M | director | Jun 18, 2026 | AWARD | 26,700 | — | — | Form 4 |
| BERGER FRANKLIN M | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| Berman Howard | director | Jun 18, 2026 | AWARD | 37,700 | $4.36 | $164.4K | Form 4 |
| Berman Howard | director | Jun 18, 2026 | AWARD | 26,700 | — | — | Form 4 |
| DUNCAN BARBARA GAYLE | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| DUNCAN BARBARA GAYLE | director | Jun 18, 2026 | AWARD | 37,700 | $4.36 | $164.4K | Form 4 |
| DUNCAN BARBARA GAYLE | director | Jun 18, 2026 | AWARD | 26,700 | — | — | Form 4 |
| DUNCAN BARBARA GAYLE | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| Polsky Bruce | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| Polsky Bruce | director | Jun 18, 2026 | AWARD | 37,700 | $4.36 | $164.4K | Form 4 |
| Polsky Bruce | director | Jun 18, 2026 | AWARD | 26,700 | — | — | Form 4 |
| Polsky Bruce | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| Murphy Polly A. | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| Murphy Polly A. | director | Jun 18, 2026 | AWARD | 37,700 | $4.36 | $164.4K | Form 4 |
| Murphy Polly A. | director | Jun 18, 2026 | AWARD | 26,700 | — | — | Form 4 |
| Murphy Polly A. | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| Adams Jerome M. | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| Adams Jerome M. | director | Jun 18, 2026 | AWARD | 37,700 | $4.36 | $164.4K | Form 4 |
| Adams Jerome M. | director | Jun 18, 2026 | AWARD | 26,700 | — | — | Form 4 |
| Adams Jerome M. | director | Jun 18, 2026 | OPTION EX. | 29,600 | — | — | Form 4 |
| KIRSCH ARTHUR S | director | Jun 18, 2026 | AWARD | 37,700 | $4.36 | $164.4K | Form 4 |
| KIRSCH ARTHUR S | director | Jun 18, 2026 | AWARD | 26,700 | — | — | Form 4 |
| Murphy Polly A. | director | May 18, 2026 | BUY | 6,100 | $4.17 | $25.4K | Form 4 |
| Murphy Polly A. | director | May 18, 2025 | BUY | 6,100 | $4.17 | $25.4K | Form 4 |
| Corcoran Andrea | See Remarks | Mar 11, 2026 | OPTION EX. | 60,000 | $1.24 | $74.4K | Form 4 |
| Corcoran Andrea | See Remarks | Mar 11, 2026 | OPTION EX. | 60,000 | $1.24 | $74.4K | Form 4 |
| Horga Maria Arantxa | Chief Medical Officer | Jan 31, 2026 | AWARD | 173,500 | $4.24 | $735.6K | Form 4 |
| Horga Maria Arantxa | Chief Medical Officer | Jan 31, 2026 | OPTION EX. | 51,283 | — | — | Form 4 |
| Horga Maria Arantxa | Chief Medical Officer | Jan 31, 2026 | TAX W/H | 16,073 | $4.24 | $68.1K | Form 4 |
| Horga Maria Arantxa | Chief Medical Officer | Jan 31, 2026 | OPTION EX. | 9,750 | — | — | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2026 | AWARD | 119,520 | $4.24 | $506.8K | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2026 | OPTION EX. | 42,083 | — | — | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2026 | TAX W/H | 11,570 | $4.24 | $49.1K | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2026 | OPTION EX. | 8,750 | — | — | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2026 | AWARD | 177,000 | $4.24 | $750.5K | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2026 | OPTION EX. | 58,050 | — | — | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2026 | TAX W/H | 14,136 | $4.24 | $59.9K | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2026 | OPTION EX. | 11,250 | — | — | Form 4 |
| Corcoran Andrea | See Remarks | Jan 31, 2026 | OPTION EX. | 54,866 | — | — | Form 4 |
| Corcoran Andrea | See Remarks | Jan 31, 2026 | TAX W/H | 16,104 | $4.24 | $68.3K | Form 4 |
| Corcoran Andrea | See Remarks | Jan 31, 2026 | AWARD | 180,000 | $4.24 | $763.2K | Form 4 |
| Corcoran Andrea | See Remarks | Jan 31, 2026 | OPTION EX. | 10,500 | — | — | Form 4 |
| Sommadossi Jean-Pierre | director, officer: President, CEO, and Chairman | Feb 3, 2026 | OPTION EX. | 300,000 | $1.24 | $372.0K | Form 4 |
| Sommadossi Jean-Pierre | director, officer: President, CEO, and Chairman | Jan 31, 2026 | OPTION EX. | 272,983 | — | — | Form 4 |
| Sommadossi Jean-Pierre | director, officer: President, CEO, and Chairman | Jan 31, 2026 | TAX W/H | 106,093 | $4.24 | $449.8K | Form 4 |
| Sommadossi Jean-Pierre | director, officer: President, CEO, and Chairman | Jan 31, 2026 | OPTION EX. | 99,517 | — | — | Form 4 |
| Sommadossi Jean-Pierre | director, officer: President, CEO, and Chairman | Feb 3, 2026 | OPTION EX. | 300,000 | $1.24 | $372.0K | Form 4 |
| Foster Wayne | EVP, Chief Accounting Officer | Jan 31, 2026 | AWARD | 108,000 | $4.24 | $457.9K | Form 4 |
| Foster Wayne | EVP, Chief Accounting Officer | Jan 31, 2026 | OPTION EX. | 41,333 | — | — | Form 4 |
| Foster Wayne | EVP, Chief Accounting Officer | Jan 31, 2026 | TAX W/H | 12,132 | $4.24 | $51.4K | Form 4 |
| Foster Wayne | EVP, Chief Accounting Officer | Jan 31, 2026 | OPTION EX. | 8,000 | — | — | Form 4 |
| Murphy Polly A. | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Murphy Polly A. | director | Jun 20, 2025 | AWARD | 41,200 | $3.25 | $133.9K | Form 4 |
| Murphy Polly A. | director | Jun 20, 2025 | AWARD | 29,600 | — | — | Form 4 |
| Murphy Polly A. | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| BERGER FRANKLIN M | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Duncan Barbara Gayle | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| BERGER FRANKLIN M | director | Jun 20, 2025 | AWARD | 41,200 | $3.25 | $133.9K | Form 4 |
| Duncan Barbara Gayle | director | Jun 20, 2025 | AWARD | 41,200 | $3.25 | $133.9K | Form 4 |
| BERGER FRANKLIN M | director | Jun 20, 2025 | AWARD | 29,600 | — | — | Form 4 |
| Duncan Barbara Gayle | director | Jun 20, 2025 | AWARD | 29,600 | — | — | Form 4 |
| BERGER FRANKLIN M | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Duncan Barbara Gayle | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Polsky Bruce | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Polsky Bruce | director | Jun 20, 2025 | AWARD | 41,200 | $3.25 | $133.9K | Form 4 |
| Polsky Bruce | director | Jun 20, 2025 | AWARD | 29,600 | — | — | Form 4 |
| Polsky Bruce | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Adams Jerome M. | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Adams Jerome M. | director | Jun 20, 2025 | AWARD | 41,200 | $3.25 | $133.9K | Form 4 |
| Adams Jerome M. | director | Jun 20, 2025 | AWARD | 29,600 | — | — | Form 4 |
| Adams Jerome M. | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Lucidi Bruno | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Lucidi Bruno | director | Jun 20, 2025 | AWARD | 41,200 | $3.25 | $133.9K | Form 4 |
| Lucidi Bruno | director | Jun 20, 2025 | AWARD | 29,600 | — | — | Form 4 |
| Lucidi Bruno | director | Jun 20, 2025 | OPTION EX. | 29,600 | — | — | Form 4 |
| Berman Howard | director | Jun 20, 2025 | AWARD | 164,800 | $3.25 | $535.6K | Form 4 |
| Berman Howard | Jun 20, 2025 | OTHER | 0 | — | — | Form 4 | |
| Kirsch Arthur S | director | Feb 20, 2025 | AWARD | 164,800 | $3.14 | $517.5K | Form 4 |
| Kirsch Arthur S | director | Feb 20, 2025 | OTHER | 0 | — | — | Form 4 |
| Kirsch Arthur S | director | Feb 20, 2025 | OTHER | 0 | — | — | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2025 | AWARD | 200,000 | $3.06 | $612.0K | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2025 | AWARD | 11,250 | — | — | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2025 | OPTION EX. | 46,800 | — | — | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2025 | TAX W/H | 14,134 | $3.06 | $43.3K | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2025 | OPTION EX. | 46,800 | — | — | Form 4 |
| Hammond Janet MJ | Chief Development Officer | Jan 31, 2025 | AWARD | 11,250 | — | — | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2025 | AWARD | 132,800 | $3.06 | $406.4K | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2025 | AWARD | 8,750 | — | — | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2025 | OPTION EX. | 33,333 | — | — | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2025 | TAX W/H | 11,517 | $3.06 | $35.2K | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2025 | OPTION EX. | 33,333 | — | — | Form 4 |
| Vavricka John | Chief Commercial Officer | Jan 31, 2025 | AWARD | 8,750 | — | — | Form 4 |
| Horga Maria Arantxa | Chief Medical Officer | Jan 31, 2025 | AWARD | 192,800 | $3.06 | $590.0K | Form 4 |
| Horga Maria Arantxa | Chief Medical Officer | Jan 31, 2025 | AWARD | 9,750 | — | — | Form 4 |